PsyAccess
Am I eligible?
Am I eligible?
Clinical trialsRegistry-verifiedDesignated-centers model

Centralny Szpital Kliniczny UM w Łodzi — Klinika Zaburzeń Afektywnych i Psychotycznych

Łódź, Poland

Treatment & access

  • Treatments offeredLSD (MM120 — clinical trial)
  • Access routeTrial
  • Cost & coverage (registry status)Free within clinical trial
  • Websitehttps://csk.umed.pl

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

About this provider

Compiled from the registry data on this page.

The Panorama study, a Phase 3 clinical trial of MM120 (lysergide, a pharmaceutical form of LSD) in generalized anxiety disorder, lists Centralny Szpital Kliniczny UM w Łodzi — Klinika Zaburzeń Afektywnych i Psychotycznych in Łódź, Poland, among its sites. The trial is registered on ClinicalTrials.gov under NCT06809595, the registry source cited by this record. As of 2026-08-07 the registry status is ACTIVE_NOT_RECRUITING: recruitment has closed, so this site is not accepting new participants. For enrolled participants, treatment within the trial is free of charge. The record was last verified on 2026-08-07.

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Clinical trials access in Poland follows published criteria. A short pre-screening comes first — then your compiled summary goes to Centralny Szpital Kliniczny UM w Łodzi — Klinika Zaburzeń Afektywnych i Psychotycznych only with your explicit consent, and you can download it for yourself either way.

Check my fit & enquire

About two minutes. The check itself runs in your browser — your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.

Check my fit & enquire